Experience of tailoring prophylaxis using factor VIII pharmacokinetic parameters estimated with myPKFiT® in patients with severe haemophilia A without inhibitors

Haemophilia. 2017 Jan;23(1):e50-e54. doi: 10.1111/hae.13141.
No abstract available

Publication types

  • Letter

MeSH terms

  • Factor VIII / pharmacokinetics
  • Factor VIII / therapeutic use*
  • Hemophilia A / drug therapy*
  • Humans
  • Male

Substances

  • Factor VIII